Boswellia Active
Natural health product licensed in Canada
- Other names
- Active Mobility, Boswell Sports
- Licence holder
- Renu Bio Health Ltd.
- NPN or DIN-HM
- 80143021
- Status
- Active licence
- Licence date
- 29 July 2025
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bore Source : Citrate de bore | 0.5 mg | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 1,200 mg | 200 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 20 mg | 60,000 µg |
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Potency : 40 % Boswellic acids | 333 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 50 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 50 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 8 µg | 24 µg |
| Manganèse Source : Diglycinate de manganèse (II) | 1 mg | 3,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 30 µg | 90 µg |
| Calcium Source : Citrate de calcium | 100 mg | 300,000 µg |
| Bêta-carotène Source : bêta-carotène | 3 mg | Not calculated |
Non-medicinal ingredients
Acide ascorbique, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps in the development and maintenance of bones. Helps in the maintenance of bones. Helps maintain healthy calcium metabolism. Helps relieve joint pain and swelling associated with osteoarthritis of the knee. Helps support joint health. Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80143021
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.